These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 20533520

  • 1. Anaphylactoid reaction to high-dose methotrexate and successful desensitization.
    Oulego-Erroz I, Maneiro-Freire M, Bouzón-Alejandro M, Vázquez-Donsión M, Couselo JM.
    Pediatr Blood Cancer; 2010 Sep; 55(3):557-9. PubMed ID: 20533520
    [Abstract] [Full Text] [Related]

  • 2. Anaphylactoid reaction to high-dose methotrexate and re-administration after a successful desensitization.
    Caldeira T, Costa V, Silva I, Oliva T, Norton L.
    Pediatr Hematol Oncol; 2008 Mar; 25(2):131-4. PubMed ID: 18363180
    [Abstract] [Full Text] [Related]

  • 3. Delayed renal excretion of methotrexate after a severe anaphylactic reaction to methotrexate in a child with osteosarcoma.
    Ozguven AA, Uysal K, Gunes D, Koroglu T, Gurcu O, Olgun N.
    J Pediatr Hematol Oncol; 2009 Apr; 31(4):289-91. PubMed ID: 19346884
    [Abstract] [Full Text] [Related]

  • 4. Management and successful desensitization in methotrexate-induced anaphylaxis.
    Bouchireb K, Dodille A, Ponvert C, Gouraud F, Dubrel M, Brugières L.
    Pediatr Blood Cancer; 2009 Feb; 52(2):295-7. PubMed ID: 18855892
    [Abstract] [Full Text] [Related]

  • 5. Successful desensitization to high-dose methotrexate after systemic anaphylaxis.
    Davis KA, Williams P, Walker JC.
    Ann Allergy Asthma Immunol; 2003 Jan; 90(1):87-9. PubMed ID: 12546343
    [Abstract] [Full Text] [Related]

  • 6. The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue.
    Zelcer S, Kellick M, Wexler LH, Gorlick R, Meyers PA.
    Pediatr Blood Cancer; 2008 Jun; 50(6):1176-80. PubMed ID: 18266225
    [Abstract] [Full Text] [Related]

  • 7. Anaphylaxis during the first course of high-dose methotrexate: a case report and literature review.
    Pugi A, Benemei S, Vietri M, Tondo A, Calvani AM, Mugelli A, Vannacci A, Lapi F.
    J Clin Pharm Ther; 2012 Apr; 37(2):245-8. PubMed ID: 21569069
    [Abstract] [Full Text] [Related]

  • 8. High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma.
    Crews KR, Liu T, Rodriguez-Galindo C, Tan M, Meyer WH, Panetta JC, Link MP, Daw NC.
    Cancer; 2004 Apr 15; 100(8):1724-33. PubMed ID: 15073863
    [Abstract] [Full Text] [Related]

  • 9. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma.
    Widemann BC, Balis FM, Kempf-Bielack B, Bielack S, Pratt CB, Ferrari S, Bacci G, Craft AW, Adamson PC.
    Cancer; 2004 May 15; 100(10):2222-32. PubMed ID: 15139068
    [Abstract] [Full Text] [Related]

  • 10. Acute transient cerebral toxicity associated with administration of high-dose methotrexate.
    Mittal R, Mottl H, Nemec J.
    Med Princ Pract; 2005 May 15; 14(3):202-4. PubMed ID: 15863997
    [Abstract] [Full Text] [Related]

  • 11. Ambulatory high-dose methotrexate administration among pediatric osteosarcoma patients in an urban, underserved setting is feasible, safe, and cost-effective.
    Mahadeo KM, Santizo R, Baker L, Curry JO, Gorlick R, Levy AS.
    Pediatr Blood Cancer; 2010 Dec 15; 55(7):1296-9. PubMed ID: 20949591
    [Abstract] [Full Text] [Related]

  • 12. [Evaluation of severe side effects of high-dose methotrexate in osteosarcoma].
    Umeda T, Takada N, Hodaka E, Endoh F, Ishii T.
    Gan To Kagaku Ryoho; 1984 Feb 15; 11(2):285-94. PubMed ID: 6582805
    [Abstract] [Full Text] [Related]

  • 13. Toxic encephalopathy and delayed MTX clearance after high-dose methotrexate therapy in a child homozygous for the MTHFR C677T polymorphism.
    Müller J, Kralovánszky J, Adleff V, Pap E, Németh K, Komlósi V, Kovács G.
    Anticancer Res; 2008 Feb 15; 28(5B):3051-4. PubMed ID: 19031955
    [Abstract] [Full Text] [Related]

  • 14. Outpatient high-dose methotrexate: proceed with extreme caution, if at all.
    Womer RB.
    Pediatr Blood Cancer; 2010 Dec 15; 55(7):1250-1. PubMed ID: 20981687
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anaphylactoid reactions to methotrexate.
    Alkins SA, Byrd JC, Morgan SK, Ward FT, Weiss RB.
    Cancer; 1996 May 15; 77(10):2123-6. PubMed ID: 8640680
    [Abstract] [Full Text] [Related]

  • 18. High-dose methotrexate-induced bullous variant of acral erythema.
    Hellier I, Bessis D, Sotto A, Margueritte G, Guilhou JJ.
    Arch Dermatol; 1996 May 15; 132(5):590-1. PubMed ID: 8624164
    [No Abstract] [Full Text] [Related]

  • 19. Methotrexate-induced bullous acral erythema in a child.
    Werchniak AE, Chaffee S, Dinulos JG.
    J Am Acad Dermatol; 2005 May 15; 52(5 Suppl 1):S93-5. PubMed ID: 15858519
    [Abstract] [Full Text] [Related]

  • 20. [Toxicosis of high-dose methotrexate (HD-MTX) for osteosarcoma, cured with treatment by leucovorin (LV) rescue and hemoperfusion--a case report].
    Kobayashi H, Morita T, Hirata Y, Kato T, Okada Y, Sato T.
    Gan To Kagaku Ryoho; 2000 Mar 15; 27(3):475-8. PubMed ID: 10740644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.